Precision medicine for patients with lymphoma; the Bloodwise Precision Medicine for Aggressive Lymphomas (PMAL) consortium

Bridgin Merron, Shamim Kazmi-Stokes, Thomas Cummin,Sharon Barrans,Shamzah Araf,Koorosh Korfi,Laura D Lopez Pascua,Josh Caddy,Kelly Cozens,Francesco Cucco,Rahman Uddin,Chulin Sha,Reuben Tooze,Gareth Griffiths,Ming Qing Du,Cathy Burton,David Westhead,Jude Fitzgibbon,Anna Schuh,Andrew Davies,Peter Johnson

Clinical Medicine（2019）

引用 0|浏览51

暂无评分

摘要

While conventional therapy is curative for most patients with high grade lymphomas, there is considerable heterogeneity in this diagnosis, with scope to refine treatment according to the precise molecular phenotype. This is increasingly used to guide specific therapy and to predict outcomes. The

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要